Ourania Kostopoulou

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Article: MOLECULAR THERAPY ONCOLOGY. 2026;34(3):201283
Dual targeting of PI3K and FGFR or CDK4/6 reveals synergistic responses in HPV-positive and HPV-negative oropharyngeal cancer spheroids
Birgersson M; Lukoseviciute M; Kostopoulou ON; Dalianis T
Article: MOLECULAR ONCOLOGY. 2026;20(7):1800-1813
Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model
Lukoseviciute M; Birgersson M; Ceriani P; Wilhelm M; Kostopoulou ON
Article: SCIENTIFIC REPORTS. 2025;15(1):44236
Circulating cell free HPVDNA in HPV positive head and neck cancer reveals fast responders and early peakers during treatment
Zupancic M; Birgersson M; Kostopoulou ON; Marklund L; Bark R; Friesland S; Jylha C; Tham E; Nasman A; Sivars L; Dalianis T
Article: ANTICANCER RESEARCH. 2025;45(11):4729-4742
Fibroblast Supernatants Modulate Treatment Responses in Human Papillomavirus Positive and Negative Oropharyngeal Cancer Cell Lines
Birgersson M; Chabanova T; Wiechec E; Kostopoulou ON; Dalianis T
Article: JOURNAL OF INTERNAL MEDICINE. 2025;297(6):608-629
Therapeutic options for human papillomavirus-positive tonsil and base of tongue cancer
Zupancic M; Kostopoulou ON; Marklund L; Dalianis T
Article: BIOMEDICINE & PHARMACOTHERAPY. 2024;180:117500
Enhancing targeted therapy by combining PI3K and AKT inhibitors with or without cisplatin or vincristine in medulloblastoma cell lines in vitro
Lukoseviciute M; Need E; Birgersson M; Dalianis T; Kostopoulou ON
Article: BIOMEDICINE & PHARMACOTHERAPY. 2024;177:116993
Combined targeted therapy with PI3K and CDK4/6, or FGFR inhibitors show synergistic effects in a neuroblastoma spheroid culture model
Lukoseviciute M; Need E; Holzhauser S; Dalianis T; Kostopoulou ON
Article: ANTICANCER RESEARCH. 2024;44(5):1863-1876
Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal Cancer Cell Lines Regardless of HPV Status
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Article: ORAL ONCOLOGY. 2024;151:106749
Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival
Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylha C; Marklund L; Nasman A; Sivars L; Dalianis T
Article: ONCOLOGY REPORTS. 2023;50(3):166
Efficacy of combined targeted therapy with PI3K and CDK4/6 or PARP and WEE1 inhibitors in neuroblastoma cell lines
Lukoseviciute M; Holzhauser S; Pappa E; Mandal T; Dalianis T; Kostopoulou ON
Article: ONCOLOGY REPORTS. 2023;49(6):125
Combination of PARP and WEE1 inhibitors in vitro: Potential for use in the treatment of SHH medulloblastoma
Lukoseviciute M; Theodosopoulou A; Holzhauser S; Dalianis T; Kostopoulou ON
Article: CANCERS. 2023;15(7):1954
High Levels of FGF11 Correlate with Poor Survival in Patients with Human Papillomavirus (HPV)-Positive Oropharyngeal Squamous Cell Carcinoma
de Flon CH; Haeggblom L; Holzhauser S; Kostopoulou ON; Zupancic M; Dalianis T; Munck-Wikland E; Marklund L; Nasman A
Article: CANCERS. 2022;15(1):93
Targeted Therapy with PI3K, PARP, and WEE1 Inhibitors and Radiotherapy in HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy while Effects with APR-246 Are Limited
Byskata K; Lukoseviciute M; Tuti F; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Article: VIRUSES-BASEL. 2022;14(7):1372
Targeted Therapy of HPV Positive and Negative Tonsillar Squamous Cell Carcinoma Cell Lines Reveals Synergy between CDK4/6, PI3K and Sometimes FGFR Inhibitors, but Rarely between PARP and WEE1 Inhibitors
Kostopoulou ON; Zupancic M; Pont M; Papin E; Lukoseviciute M; Mikelarena BA; Holzhauser S; Dalianis T
Article: FRONTIERS IN ONCOLOGY. 2021;11:748657
Targeting PI3K, FGFR, CDK4/6 Signaling Pathways Together With Cytostatics and Radiotherapy in Two Medulloblastoma Cell Lines
Lukoseviciute M; Maier H; Poulou-Sidiropoulou E; Rosendahl E; Holzhauser S; Dalianis T; Kostopoulou ON
Article: MICROORGANISMS. 2021;9(6):1137
Human Cytomegalovirus Reduces Endothelin-1 Expression in Both Endothelial and Vascular Smooth Muscle Cells
Yaiw K-C; Mohammad A-A; Taher C; Cui HL; Costa H; Kostopoulou ON; Jung M; Assinger A; Wilhelmi V; Yang J; Straat K; Rahbar A; Pernow J; Soderberg-Naucler C
Article: FRONTIERS IN ONCOLOGY. 2021;11:640490
Targeted Therapy With PI3K and FGFR Inhibitors on Human Papillomavirus Positive and Negative Tonsillar and Base of Tongue Cancer Lines With and Without Corresponding Mutations
Holzhauser S; Wild N; Zupancic M; Ursu RG; Bersani C; Nasman A; Kostopoulou ON; Dalianis T
Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021;22(7):3664
Heterogeneities in Cell Cycle Checkpoint Activation Following Doxorubicin Treatment Reveal Targetable Vulnerabilities in TP53 Mutated Ultra High-Risk Neuroblastoma Cell Lines
Jonsson LO; Sahi M; Lopez-Lorenzo X; Keller FL; Kostopoulou ON; Herold N; Ahrlund-Richter L; Fard SS
Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2021;58(2):211-225
Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines
Holzhauser S; Lukoseviciute M; Papachristofi C; Vasilopoulou C; Herold N; Wickstrom M; Kostopoulou ON; Dalianis T
Article: BIOLOGY-BASEL. 2020;9(3):E44-44
Human Cytomegalovirus Infection Induces High Expression of Prolactin and Prolactin Receptors in Ovarian Cancer
Rahbar A; AlKharusi A; Costa H; Pantalone MR; Kostopoulou ON; Cui HL; Carlsson J; Radestad AF; Soderberg-Naucler C; Norstedt G
Visa fler

Alla övriga publikationer

Review: ANTICANCER RESEARCH. 2023;43(9):3829-3839
New Approaches Towards Targeted Therapy for Childhood Neuroblastoma
Dalianis T; Lukoseviciute M; Holzhauser S; Kostopoulou ON
Review: VIRUSES-BASEL. 2021;13(5):910
Prognostic Markers and Driver Genes and Options for Targeted Therapy in Human-Papillomavirus-Positive Tonsillar and Base-of-Tongue Squamous Cell Carcinoma
Nasman A; Holzhauser S; Kostopoulou ON; Zupancic M; Ahrlund-Richter A; Du J; Dalianis T
Review: ANTICANCER RESEARCH. 2021;41(4):1715-1726
New Approaches in Targeted Therapy for Medulloblastoma in Children
Maier H; Dalianis T; Kostopoulou ON

Forskningsbidrag

Precision Medicine in Neuroblastoma - from bench to bedside 2026
Barncancerfonden
1 januari 2025 - 31 december 2025

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI